Professor Andrew Fisher

Professor Andrew Fisher is Professor of Respiratory Transplant Medicine at Newcastle University, Deputy Directory of the National Institute for Health and Care Research (NIHR) Blood and Transplant Research Unit (BTRU) in Organ Donation and Transplantation, and Honorary Consultant Chest Physician at The Newcastle upon Tyne Hospitals NHS Foundation Trust. He is also a Past President of the International Society for Heart and Lung Transplantation and currently a member of the British Transplant Society Council.

His work covers basic, translational and clinical studies into the aetiology, mechanisms, prognosis and therapeutics of inflammatory and fibrotic lung diseases. Major research themes include a specific interest in the optimisation of donor organs prior to lung transplantation, early outcomes after transplantation and chronic lung allograft dysfunction (CLAD), in order to optimise the quality of donor organs for transplant and improve the survival of patients after lung transplant.

Professor Fisher is currently leading the E-CLAD UK Trail, which is sponsored by The Newcastle upon Tyne Hospitals NHS Foundation Trust and funded by the Efficacy and Mechanism Evaluation (EME) Programme, an NIHR and Medical Research Council partnership. The aim of the E-CLAD UK study is to see if adding a course of ECP to current treatment is more effective at stabilising the function of transplanted lungs compared to standard treatments for CLAD.

Leave a comment